| 401. | | | Performance of CarbaNP and CIM tests in OXA-48 carbapenemase-producing Enterobacteriaceae
|
| 402. | | | Phage therapy in lung infections caused by multidrug-resistant Pseudomonas aeruginosa - A literature review
|
| 403. | | | Phagetherapy updates: New frontiers against antibiotic resistance
|
| 404. | | | Phenotypic and molecular identification of vancomycin resistance in clinical Staphylococcus aureus isolates in Osogbo, Nigeria
|
| 405. | | | Plasmid copy number and qnr gene expression in selection of fluoroquinolone-resistant Escherichia coli
|
| 406. | | | Plasmid-mediated quinolone resistance among extended spectrum beta lactamase producing Enterobacteriaceae from bloodstream infections
|
| 407. | | | Plasmid-mediated quinolone resistance determinants in Enterobacteriaceae from urine clinical samples
|
| 408. | | | A polirezisztens tuberkulózis gyakorisága : Ebola szárnyakkal
|
| 409. | | | Prevalence and antifungal drug resistance of dermatophytes in the clinical samples from Pakistan
|
| 410. | | | Prevalence and antimicrobial resistance of bacterial enteropathogens in Crete, Greece, during 2011-2022
|
| 411. | | | Prevalence and characteristics of ESBL-producing Salmonella in Weifang, China
|
| 412. | | | Prevalence and genetic characteristics of Staphylococcus aureus isolates from cell phones of medical students from Iran
|
| 413. | | | Prevalence and molecular epidemiology of ceftaroline non-susceptible methicillin-resistant Staphylococcus aureus isolates, first clinical report from Iran
|
| 414. | | | Prevalence and molecular mechanisms of colistin resistance in Acinetobacter baumannii clinical isolates in Tehran, Iran
|
| 415. | | | Prevalence, antibiotic resistance and molecular characterization of virulence factors of Helicobacter pylori strains isolated from patients with dyspepsia
|
| 416. | | | Prevalence of antimicrobial resistance in Campylobacter spp.: A review of the literature
|
| 417. | | | Prevalence of carbapenem-hydrolyzing OXA-type ß-lactamases among Acinetobacter baumannii in patients with severe urinary tract infection
|
| 418. | | | The prevalence of CTX-M-15 extended-spectrum ß-lactamases among Salmonella spp. and Shigella spp. isolated from three Iranian hospitals
|
| 419. | | | Prevalence of resistance mutations associated with integrase inhibitors in therapy-naive HIV-positive patients in Hungary
|
| 420. | | | Prevalence of trimethoprim/sulfamethoxazole resistance genes among Stenotrophomonas maltophilia clinical isolates in Egypt
|
| 421. | | | Prevalence of VIM- and GIM-producing Acinetobacter baumannii from patients with severe urinary tract infection
|
| 422. | | | Primorezisztencia vizsgálat 1996-ban budapesti gümőkóros betegeknél
|
| 423. | | | Primorezisztencia és rezisztencia vizsgálat budapesti gümőkórós betegeknél
|
| 424. | | | Probiotikumok az antibiotikum-rezisztencia-krízis küszöbén : megnyugtató megoldás, vagy újabb veszélyforrás?
|
| 425. | | | Probléma baktériumok - rezisztencia problémák
|
| 426. | | | Prosztatabiopszia után kialakult kétoldali psoas tályog esete
|
| 427. | | | Public health advocacy for the Berlin Declaration on tuberculosis in the former Soviet Union: the view of Médecins Sans Frontieres
|
| 428. | | | Public knowledge, attitude and practices towards antibiotics and antibiotic resistance: a cross-sectional study in Szeged District, Hungary
|
| 429. | | | Pánrezisztens kórokozók által okozott többlethalálozás: mi áll valójában a szakirodalomban?
|
| 430. | | | Quorum-sensing network-associated gene regulation in Gram-positive bacteria
|
| 431. | | | Rapid identification of Acinetobacter spp. by fluorescence in situ hybridization (FISH) from colony and blood culture material
|
| 432. | | | Rare occurrence of mupirocin resistance among clinical Staphylococcus isolates in Jordan
|
| 433. | | | Recent insight into strategies for the design of antimicrobial peptides (AMPs)
|
| 434. | | | Relationship between MLSB resistance and the prevalent virulence genotypes among Bulgarian Staphylococcus aureus isolates
|
| 435. | | | Renális denerváció - új adatok
|
| 436. | | | Resistance and heteroresistance to colistin among clinical isolates of Acinetobacter baumannii
|
| 437. | | | Resistance of Escherichia coli to some antibiotics and biocids in the intestinal biofilm of mice
|
| 438. | | | Retrospective analysis of antibiotic resistance profiles and frequency of resistance genes in clinical Stenotrophomonas maltophilia isolates
|
| 439. | | | A review of the antimicrobial and immune-modulatory properties of the gut microbiota-derived short chain fatty acid propionate - What is new?
|
| 440. | | | Review of therapeutic options for infections with carbapenem-resistant Klebsiella pneumoniae
|
| 441. | | | Rezisztencia elleni gyógyszerek tervezése
|
| 442. | | | Rezisztencia nehezíti az antimikotikus kezeléseket : innovatív terápiákra lesz szükség
|
| 443. | | | Rezisztencia problémák - probléma baktériumok
|
| 444. | | | Rezisztenciaviszonyok elemzése Escherichia coli és Klebsiella spp. húgyúti izolátumokban ismert és újszerű, klinikailag releváns indikátorok felhasználásával: 10 éves retrospektív vizsgálat
|
| 445. | | | Rezisztens hipertónia
|
| 446. | | | A rezisztens hipertónia
|
| 447. | | | A rezisztens hipertónia korszerű kezelése
|
| 448. | | | A rezisztens kórokozók terjedése - globális probléma
|
| 449. | | | A rezisztens tuberculosis világméretű terjedése és hazai járványtani vonatkozásai
|
| 450. | | | Reális lehetőség az antibiotikum-rezisztencia korában : elfelejtett antibiotikumok új szerepben
|
